Literature DB >> 10949081

Orexins (hypocretins): novel hypothalamic peptides with divergent functions.

M S Mondal1, M Nakazato, S Matsukura.   

Abstract

The hypothalamus is the most important region in the control of food intake and body weight. The ventromedial "satiety center" and lateral hypothalamic "feeding center" have been implicated in the regulation of feeding and energy homeostasis by various studies of brain lesions. The discovery of orexin peptides, whose neurons are localized in the lateral hypothalamus and adjacent areas, has given us new insight into the regulation of feeding. Dense fiber projections are found throughout the brain, especially in the raphe nucleus, locus coeruleus, paraventricular thalamic nucleus, arcuate nucleus, and central gray. Orexins mainly stimulate food intake, but by the virtue of wide immunoreactive projections throughout the brain and spinal cord, orexins interact with various neuronal pathways to potentiate divergent functions. In this review, we summarize recent progress in the physiological, neuroanatomical, and molecular studies of the novel neuropeptide orexins (hypocretins).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949081

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  4 in total

1.  Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus.

Authors:  Matthew J Follwell; Alastair V Ferguson
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 2.  Energy regulatory signals and food reward.

Authors:  Dianne P Figlewicz; Alfred J Sipols
Journal:  Pharmacol Biochem Behav       Date:  2010-03-15       Impact factor: 3.533

Review 3.  Insulin, leptin, and food reward: update 2008.

Authors:  Dianne P Figlewicz; Stephen C Benoit
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-22       Impact factor: 3.619

4.  The in vitro regulation of growth hormone secretion by orexins.

Authors:  Chen Chen; Ruwei Xu
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.